Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary SiteHidetoshi Hayashi, Kazuhiko Nakagawa, Kazuko Sakai et al.|Journal of Clinical Oncology|2019Cited by 168
Site-Specific and Targeted Therapy Based on Molecular Profiling by Next-Generation Sequencing for Cancer of Unknown Primary SiteHidetoshi Hayashi, Kazuhiko Nakagawa, Yoshihiko Segawa et al.|JAMA Oncology|2020Cited by 119